Jena / Munich, Germany | 7 December 2020 | ZEISS Research Microscopy Solutions

ZEISS is expanding its imaging technology capabilities with 3D and big image data software by acquiring a majority stake in the imaging business of arivis. With this investment, ZEISS is further strengthening its software competencies and market position in 3D image visualization, image processing, and analysis software for research microscopy. Both companies have a long-standing collaboration and strategic partnership, as arivis has been an important development partner for ZEISS for more than seven years.

“ZEISS is complementing its portfolio with highly innovative solutions and technologies that strengthen our leading position,” says Dr. Jochen Peter, member of the ZEISS Group Executive Board responsible for the Industrial Quality & Research segment, which includes the microscopy business. “This investment is in line with our strategy, which is focused on our customers’ successes and the continuing expansion of our digital solutions.”

Dr. Michael Albiez, Head of ZEISS Research Microscopy Solutions, explains: “With this combination of the businesses, we are significantly developing our software competences further in the area of microscopy solutions for research especially when it comes to 3D image processing, visualization and analysis. Modern microscope systems with high-resolution optics are recording ever increasing amounts of data, and advanced software solutions help researchers to effectively analyze their data in a streamlined way, increasing their efficiency in research. Customers and users will benefit from the further integration of the software and hardware solutions from ZEISS and arivis.”

“This move brings our collaboration with ZEISS and arivis to a completely new level and takes a real long-term perspective. This will clearly help arivis to enable our customers to reach a new dimension in processing, displaying and analyzing the enormous growth and importance of image data,” says Andreas Suchanek, CEO and founder of arivis who will, together with the arivis team, drive the expansion of joint capabilities with ZEISS. Thus, Christian Götze will become Chief Technology Officer (CTO) of arivis.

The legal form of arivis AG will remain unchanged for the time being. All permanent employees of the imaging business of arivis will continue in their current positions. Both sides have agreed not to disclose the financial details of this transaction.

arivis AG is a fast-growing, privately held software company providing imaging science solutions to researchers and enterprises engaged in all aspects of life science – from basic research and discovery to application. A broad product portfolio and range of expertise enables arivis to fulfill both industry and academic requirements. The products leverage innovative technologies to provide effective, efficient, and scalable applications and systems that solve problems at multiple levels in scientific organizations. arivis’ customers include small to medium sized biotech companies, leading medical device and pharmaceutical companies, CROs and internationally renowned research organizations and universities. arivis is headquartered in Rostock (Germany) with further locations in Munich (Germany), London (United Kingdom) and Washington D.C. (United States). The company serves customers in more than 30 countries around the world.